MedTrace Logo

The Vascutek Custom Fenestrated Anaconda Post-Market Surveillance Study

NCT01826344 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 628

Last updated 2015-12-09

No results posted yet for this study

Summary

This is a multicentre, prospective, observational post-market registry (follow-up 1 month, 1 year, 2 years, 3 years, 4 years and 5 years) to monitor the post-market clinical safety and effectiveness of the Vascutek AnacondaTM Custom Fenestrated Stent Graft in patients with a short infrarenal neck of \<15mm or juxta-renal abdominal aortic aneurysms who, in the opinion of the treating physician, are anatomically suitable for the AnacondaTM Custom Fenestrated Stent Graft and for whom a customised medical device is required.

Conditions

  • Abdominal Aortic Aneurysms (AAA)

Sponsors & Collaborators

  • Vascutek Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Austria
  • Belgium
  • Canada
  • France
  • Germany
  • Italy
  • Monaco
  • Netherlands
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01826344 on ClinicalTrials.gov